Search research articles
Contact Us
Filters
Showing results (461-470 of 703) with videos related to
Page
of 71
Sort By:
Journal of Translational Medicine
|
April 13, 2023
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach
Yizhe Mao, Tuba N Gide, Nurudeen A Adegoke, et al.
Cell
|
September 9, 2017
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas, Reinhard Dummer, Igor Puzanov, et al.
The Lancet. Oncology
|
February 2, 2015
Expanded access programmes: patient interests versus clinical trial integrity
Paul Lorigan, Paolo A Ascierto, Reinhard Dummer, et al.
Nature Medicine
|
October 16, 2023
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial
John M Kirkwood, Michele Del Vecchio, Jeffrey Weber, et al.
Cancer Immunology Research
|
March 22, 2019
CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor Function
Deepak Mittal, Ailin Lepletier, Jason Madore, et al.
The Lancet. Oncology
|
October 12, 2012
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
Georgina V Long, Uwe Trefzer, Michael A Davies, et al.
NPJ Precision Oncology
|
July 18, 2024
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab
Helen Gogas, Shruthi Ravimohan, Antara Datta, et al.
The New England Journal of Medicine
|
June 20, 2024
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
Georgina V Long, Axel Hauschild, Mario Santinami, et al.
The Lancet. Oncology
|
March 28, 2024
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis
Robert C Stassen, Carolien C H M Maas, Astrid A M van der Veldt, et al.
Journal for Immunotherapy of Cancer
|
September 12, 2022
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites
Jordan W Conway, Robert V Rawson, Serigne Lo, et al.
Page
of 71
Search research articles
Search
Showing results (461-470 of 703) with videos related to
Sort By:
Page
of 71
Journal of Translational Medicine
|
April 13, 2023
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach
Yizhe Mao, Tuba N Gide, Nurudeen A Adegoke, et al.
Cell
|
September 9, 2017
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas, Reinhard Dummer, Igor Puzanov, et al.
The Lancet. Oncology
|
February 2, 2015
Expanded access programmes: patient interests versus clinical trial integrity
Paul Lorigan, Paolo A Ascierto, Reinhard Dummer, et al.
Nature Medicine
|
October 16, 2023
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial
John M Kirkwood, Michele Del Vecchio, Jeffrey Weber, et al.
Cancer Immunology Research
|
March 22, 2019
CD96 Is an Immune Checkpoint That Regulates CD8<sup>+</sup> T-cell Antitumor Function
Deepak Mittal, Ailin Lepletier, Jason Madore, et al.
The Lancet. Oncology
|
October 12, 2012
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
Georgina V Long, Uwe Trefzer, Michael A Davies, et al.
NPJ Precision Oncology
|
July 18, 2024
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab
Helen Gogas, Shruthi Ravimohan, Antara Datta, et al.
The New England Journal of Medicine
|
June 20, 2024
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
Georgina V Long, Axel Hauschild, Mario Santinami, et al.
The Lancet. Oncology
|
March 28, 2024
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis
Robert C Stassen, Carolien C H M Maas, Astrid A M van der Veldt, et al.
Journal for Immunotherapy of Cancer
|
September 12, 2022
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites
Jordan W Conway, Robert V Rawson, Serigne Lo, et al.
Page
of 71